European Commission - Enterprise and Industry

For a better experience, please enable Javascript!

Technological Smes for the Health Industry

Details
Level: National and Regional Event
Title of the Event: Technological Smes for the Health Industry
Description of the event:

Ageing population, safeguarding a healthy workforce, and an emerging demand for quality and highly professional health services have boosted the significance of the health sector. The health sector absorbs large amounts of labour, commodities and research and thus creates incomes, which in turn flow back into the economic cycle of locations, regions and the overall economy. SMEs are the main origins of innovation in the health sector, and are catalysts of growth and competitiveness. As such their needs must be considered when drawing up successful EU and regional policies for health and industry. This is the competence of regional/local public authorities providing health services and developing the sector in their regions. Europe 2020 Strategy focuses positively on strengthening and further developing EU policies that support innovation particularly for small and medium-sized enterprises (SMEs). The European medical technology industry – one of the most innovative in the world – is well positioned for healthy growth under this policy objective. Comprised primarily of SMEs, which make up 80% of the industry, the sector is a major provider of jobs, especially highly skilled jobs in research and manufacturing, and employs nearly 534,000 people across Europe. The European Commission, in its recent Exploratory Process on the Future of the Medical Devices Sector, found that the sector depends on a healthy stream of SMEs to develop new ideas and create new technologies. One of the three issues emphasised by that process was the need to support SMEs “… to ensure the competitiveness of the sector through the encouragement of research and development, clusters and aspects of intellectual property, regulatory matters and general trade issues.” SMEs are also important to Europe in that they can act as a barometer for EU competitiveness and innovativeness. A survey of 12 National Industry Associations (including all the major medical technology exporters) across Europe has identified almost 7,000 SMEs that design and manufacture medical devices and diagnostic products. These companies face significant barriers that prevent them from reaching their potential. Specifically, we have found that SMEs have difficulty with product registration, reimbursement, procurement, distribution channels, health technology assessment and access to R&D incentives. Innovation in medical technology has the power to increase the efficiency and effectiveness of care, either by revolutionary steps in medical prevention, diagnosis and treatment, or by the application of innovative technology that is able to do more with less. Innovative technologies will provide Europe with more sustainable healthcare delivery and a more competitive industry, and because SMEs are such a vital source of such solutions, their needs must be taken into account when drawing up successful policies for health and industry. Conclusion:  Big challenges have small and medium-sized solutions

Event website: www.tecnopolispst.it
Contact e-mail : a.maddaluno@tno.it
Estimated Number of Participants: 500
Attachment(s): General Program (1.22 MB)
   
Where & When
Language(s): italiano
Countries involved: Italy (IT)

16/11/2015 - 20/11/2015
09:00 to 19:30

Tecnopolis, Science and Technology Park
Str. P.le per Casamassima, km. 3 -
Valenzano (Bari)
Italy (IT)

Verify address on map
Categories
Type of Event: Entrepreneur's Day
Topic(s) addressed: Starting up a business
Innovation/Technology
Entrepreneurship education
Environment/energy efficiency
Entrepreneurship
Youth entrepreneurship
Target Audience: Established Entrepreneurs/practitioners
Potential Entrepreneurs
Students
New entrepreneurs
Organisers

Main Organiser

Tecnopolis Pst